These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36279714)

  • 1. Correlation between neutrophil-to-lymphocyte ratio and severity of myasthenia gravis in adults: A retrospective study.
    Duan Z; Jia A; Cui W; Feng J
    J Clin Neurosci; 2022 Dec; 106():117-121. PubMed ID: 36279714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The correlation of neutrophil-to-lymphocyte ratio with the presence and short-time curative effect of myasthenia gravis in children: a retrospectively study.
    Jiang Z; Ning Z; Yang L; Chen B; Tang J; Zhang J; Fang H; Xu R; Guo F; Chen M; Sun K
    Int J Neurosci; 2021 Sep; 131(9):894-901. PubMed ID: 32315556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation of neutrophil-to-lymphocyte ratio with the presence and activity of myasthenia gravis.
    Yang DH; Qian MZ; Wei MM; Li J; Yu MM; Lu XM; Yang H; Lin H; Li X; Zhu JY; Zhang X
    Oncotarget; 2017 Sep; 8(44):76099-76107. PubMed ID: 29100295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The quantitative myasthenia gravis score: comparison with clinical, electrophysiological, and laboratory markers.
    Barnett C; Katzberg H; Nabavi M; Bril V
    J Clin Neuromuscul Dis; 2012 Jun; 13(4):201-5. PubMed ID: 22622164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No correlation between acetylcholine receptor antibody concentration and individual clinical symptoms of myasthenia gravis: A systematic retrospective study involving 67 patients.
    Wang L; Wang S; Yang H; Han J; Zhao X; Han S; Zhang Y; Lv J; Zhang J; Li M; Ji Y; Zhou S; He X; Fang H; Yang J; Zhang Y; Zhang Q; Gao P; Gao F
    Brain Behav; 2021 Jul; 11(7):e02203. PubMed ID: 34075720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of neutrophil-to-lymphocyte ratio between myelin oligodendrocyte glycoprotein antibody-associated disease and aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders in adults.
    Duan Z; Feng J
    J Clin Neurosci; 2022 Jul; 101():89-93. PubMed ID: 35569419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
    Howard JF; Utsugisawa K; Benatar M; Murai H; Barohn RJ; Illa I; Jacob S; Vissing J; Burns TM; Kissel JT; Muppidi S; Nowak RJ; O'Brien F; Wang JJ; Mantegazza R;
    Lancet Neurol; 2017 Dec; 16(12):976-986. PubMed ID: 29066163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neutrophil-to-lymphocyte ratio as a marker of vasculitis activity, severe infection and mortality in anca-associated vasculitis: A retrospective study.
    Fonseca JA; Gameiro J; Duarte I; Jorge S; Lopes JA
    Nefrologia (Engl Ed); 2021; 41(3):321-328. PubMed ID: 33309337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tacrolimus on soluble costimulatory molecules in patients with refractory myasthenia gravis.
    Wu H; Chen L; Zhou X; Wu Y; Yan Y; Zhu Y; Zhao C; Xue Q
    J Neuroimmunol; 2022 Nov; 372():577955. PubMed ID: 36054935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing outcome measures of disease activity in pediatric myasthenia.
    Prior DE; Cooper BA; Zhang B; Ghosh PS
    Muscle Nerve; 2021 May; 63(5):751-757. PubMed ID: 33604899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis.
    Zeng Z; Wang C; Wang B; Wang N; Yang Y; Guo S; Du Y
    Neurosci Lett; 2019 Feb; 694():129-135. PubMed ID: 30521947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of tacrolimus therapy for myasthenia gravis: A single arm meta-analysis.
    Wang L; Xi J; Zhang S; Wu H; Zhou L; Lu J; Zhang T; Zhao C
    J Clin Neurosci; 2019 May; 63():160-167. PubMed ID: 30827886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of the albumin to globulin ratio in predicting severity and prognosis in myasthenia gravis patients].
    Yang DH; Su ZQ; Chen Y; Chen ZB; Ding ZN; Weng YY; Li J; Li X; Tong QL; Han YX; Zhang X
    Zhonghua Yi Xue Za Zhi; 2016 Mar; 96(9):697-701. PubMed ID: 27055507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin for myasthenia gravis.
    Gajdos P; Chevret S; Toyka KV
    Cochrane Database Syst Rev; 2012 Dec; 12(12):CD002277. PubMed ID: 23235588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usefulness of subcutaneous immunoglobulin therapy in the management of myasthenia gravis: a retrospective cohort study.
    Barnay M; Duval F; Solé G; Carla L; Mathis S; Le Masson G
    J Neurol; 2022 Dec; 269(12):6572-6581. PubMed ID: 35995991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution characteristics and correlation analysis of antibody detection value in myasthenia gravis].
    Liu YL; Zheng YM; Luo JJ; Zhang W; Gao F; Yuan Y; Hao HJ
    Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3221-3226. PubMed ID: 31694116
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-reported burden of myasthenia gravis: baseline results of the international prospective, observational, longitudinal real-world digital study MyRealWorld-MG.
    Dewilde S; Philips G; Paci S; Beauchamp J; Chiroli S; Quinn C; Day L; Larkin M; Palace J; Berrih-Aknin S; Claeys KG; Muppidi S; Mantegazza R; Saccà F; Meisel A; Bassez G; Murai H; Janssen MF
    BMJ Open; 2023 Jan; 13(1):e066445. PubMed ID: 36720569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile and impact of comorbidities in patients with very-late-onset myasthenia gravis.
    Vijayan J; Menon D; Barnett C; Katzberg H; Lovblom LE; Bril V
    Muscle Nerve; 2021 Oct; 64(4):462-466. PubMed ID: 34235762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative Myasthenia Gravis Score: a Brazilian multicenter study for translation, cultural adaptation and validation.
    Oliveira EF; Valério BCO; Cavalcante V; Urbano JJ; Silva AS; Polaro MN; Nacif SR; Oliveira CS; Resende MBD; Oliveira ASB; Oliveira LVF
    Arq Neuropsiquiatr; 2017 Jul; 75(7):457-463. PubMed ID: 28746433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.